Interview with the President and CEO: Protagonist Therapeutics, Inc. (NASDAQ:PTGX)
Dr. Dinesh Patel has been on the board of directors and the President and Chief Executive Officer of Protagonist Therapeutics, Inc. since December 2008. He has 35 years of executive, entrepreneurial and scientific experience that span the pharmaceutical, biotechnology and biopharmaceutical industries. Earlier, he was the Chief Executive Officer and Co-Founder of Miikana Therapeutics, an oncology company. Prior to Miikana, he was a Co-Founder of Versicor, which was acquired by Pfizer in 2005 for $1.9 billion. Prior to that, he worked at Affymax and started his industrial career at Bristol-Myers Squibb in 1985. He received a doctorate in chemistry from Rutgers University and a B.S. degree in industrial chemistry from S. P. University, Vallabh Vidyanagar, India. Profile
Word count: 3,213
TWST: Could you tell me about the firm?
Dr. Patel: We are a biotech company. We are focused on innovative peptide therapeutics. We have a